Mobile device management (MDM) is a security software which is usually used by the information technology (IT) department of any company to manage, secure and monitor the different devices of employees. These devices are deployed across various mobile service providers. It comprises a range of products and services that help the organization to allow and support different applications in personal mobile devices. The Asia-Pacific MDM market is expected to reach USD 2.00 Bn by 2023 with a compound annual growth rate (CAGR) of 25.16% during 2018-2023.

The market is divided into three primary segments based on solutions, deployment and end users.
Based on solutions, the market is segmented into device management, application management, security management and network service management. With a highest CAGR of 30.45%, the device management market is expected to reach USD 0.65 Bn in the year 2023. The application management market holds the maximum share in 2018 with a revenue of USD 0.21 Bn.
Based on deployment, the market is divided into cloud and on-premise. The cloud deployment market is expected to have a larger share and is estimated to grow from USD 0.35 Bn in 2018 to USD 1.19 Bn in 2023 with a CAGR of 27.59%.
Based on end users, the market is classified into banking, financial services and insurance (bfsi), telecommunication, retail, and healthcare. Healthcare will have a major market share and will rise from USD 0.25 Bn in 2018 to USD 0.76 Bn in 2023. The CAGR will be around 24.90%.

Key growth factors

Asia-Pacific would be the fastest growing region and would register significant growth during the forecast period. Organizations in this region have been actively adopting enterprise mobility solutions to meet the demands of the dynamic mobile workforce and economic growth. Mobile devices have gained tremendous acceptance among the younger generation, and demand for cloud-based solutions by small and medium sized industries (SMEs), and the growing bring your own device (BYOD) trend would be some of the notable factors that would drive the MDM market in this region. Mobile devices in this region are being used extensively for both private and professional purpose. BYOD assists in mobilization of organizational data that increases the efficiency of the organization.

Threats and key players

The growth of the MDM market in this region is currently hindered by accidents, which is a major cause of data loss for individual users. Very often we hear people asking others how to dry a wet device. Connectivity to the cloud can enable businesses to automatically create backups. No matter what happens to a device, important data and information can be retrieved by accessing the most recent cloud backup. Initial cost of these solutions is very high and this is a hindering factor for this market. Companies here are concerned about large investments in a particular area.

What’s covered in the report?

1. Overview of the Asia-Pacific MDM learning market.
2. Market drivers and challenges of the Asia-Pacific MDM market.
3. Market trends in the Asia-Pacific MDM market.
4. Historical, current and forecasted market size data for the segment based on solutions.
5. Historical, current and forecasted market size data for the segment based on deployment.
6. Historical, current and forecasted market size data for the segment based on end users.
7. Analysis of the company profiles of major competitors operating in the market.

Why buy?

1. Understand the demand for MDM to determine the viability of the market.
2. Identify the challenge areas and address them.
3. Develop strategies based on the drivers, trends and highlights.
4. Recognize the key competitors of this market and respond accordingly.
5. Knowledge of the initiatives and growth strategies taken by the major companies and decide the direction of further growth.
6. Define the competitive positioning by comparing the products and services compared with the key players in the market.

The post Asia-Pacific Mobile Device Management (MDM) Market (2018-2023) first appeared on CRI Report.

Advanced visualization (AV) systems are medical instruments, equipped with advanced software that display the numerous aspects of living cells efficiently. They are new-generation data visualization platforms that help end users to view data in depth by providing enhanced image quality. These help specialists by providing a better understanding of various clinical issues, thus, leading to faster and higher quality healthcare. It is widely utilized in most pathological laboratories as well. They also help in targeted drug therapy, ultimately reducing the cost of the procedure. The Asia-Pacific AV market is expected to reach USD Bn by 2023 with a compound annual growth rate (CAGR) of 13.44% during 2018-2023.

The market is divided into three primary segments based on the types of product, solution and imaging modality.
Based on the types of product, the market is segmented into hardware and software and services.
Based on solution, the market is segmented into enterprise-wide thin client-based solution and standalone workstation-based solution.
Based on imaging modality, the market is classified into magnetic resonance imaging (MRI), positron emission tomography (PET), computer tomography (CT), ultrasound and x-ray.
On the basis of countries, the market is segmented into China, Japan, India, and rest of Asia-Pacific (APAC).

Key growth factors

Asia-Pacific represented more than half of the world’s population in 2016, and with the population still increasing, the demand for efficient and early diagnosis of diseases like cancer is growing continuously. The rise in disposable income as well as an increase in awareness about advanced diagnostics will drive the market. There has been a massive rise in chronic diseases in the APAC region over the past decade, mainly cancer, cardiac and neurological disorders due to increased tobacco use, alcohol consumption, etc. Using AV is one of the best ways for early detection, diagnosis and treatment of these diseases.

Threats and key players

The APAC region has a significant disparity among its various countries regarding access to healthcare facilities. Although countries such as Australia and Japan have excellent medical infrastructure and imaging technology, countries such as Bangladesh, Nepal, Afghanistan have subpar facilities. This could hamper the AV market from developing in those countries. The use of AV is complex and may require the assistance of service specialists or specialized training, which can be costly. This can hinder the growth of the market. The price of the AV tools is very high and many of the APAC countries like Bangladesh, Pakistan and Afghanistan may not be able to afford them due to poorer economic conditions prevailing in those regions, which can constrain the market.
The key competitors in the Asia-Pacific AV market are Toshiba Corporation, Ziosoft, Koninklijke Philips N.V., Afga-Gevaert, Conmed and others.

Whats covered in the report?

1. Overview of the Asia-Pacific AV learning market.
2. Market drivers and challenges of the Asia-Pacific AV market.
3. Market trends in the Asia-Pacific AV market.
4. Historical, current and forecasted market size data for the segment based on the product type – hardware and software and services.
5. Historical, current and forecasted market size data for the segment based on solution – enterprise-wide thin client-based solution and standalone workstation-based solution.
6. Historical, current and forecasted market size data for the segment based on imaging modality – magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computed tomography (CT) and x-ray.
7. Historical, current and forecasted country-wise (China, Japan, India and rest of APAC) market size data for the AV market.
8. Historical, current and forecasted market size data for country-wise segments.
9. Analysis of the company profiles of major competitors operating in the market.

Why buy?

1. Understand the demand for AV to determine the viability of the market.
2. Identify the challenge areas and address them.
3. Develop strategies based on the drivers, trends and highlights.
4. Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
5. Recognize the key competitors of this market and respond accordingly.
6. Knowledge of the initiatives and growth strategies taken by the major companies and decide the direction of further growth.
7. Define the competitive position

The post Asia-Pacific Advanced Visualization (AV) Market (2018-2023) first appeared on CRI Report.

The 3D printing in healthcare market in Asia-Pacific is expected to reach a value of USD 0.59 Bn by 2023, expanding at a compound annual growth rate (CAGR) of 26.0% during 2018-2023.
3D printing can be defined as the process of building three-dimensional solid objects from digital designs. The creation of 3D printed objects is done using various additive processes. The additive processes involves laying down successive layers of a material until the desired object is created. Each of these layers can be visualized as a thinly-sliced horizontal cross-section of the final object. 3D printing is the exact opposite of subtractive manufacturing, which involves hollowing out/carving out pieces of metal or plastic from a mass. This process opens up opportunities for the production of complex shapes using less material in comparison to traditional manufacturing methods. In the field of medicine, this procedure is used to make several objects like prosthetics and implants, using several materials like metal, plastic, etc.

Asia-Pacific will experience the highest CAGR in 3D printing in healthcare market.
The market can be classified into three primary segments based on technology, material, and type.
Based on region, the market is segmented into China, India, Japan, South Korea, Australia and New Zealand (ANZ), and the rest of Asia-Pacific.
Based on technology, the market can be segmented into laser beam melting (LBM), electron beam melting (EBM), photopolymerization, droplet deposition, laminated object manufacturing, and others.
Based on material, the sub-segments are plastic, metal, ceramic and others.
Based on type, the sub-segments include prosthetics, implants, surgical guides, hearing aid and others.
The latest trend is extensive research to make 3D printed products commercially viable.

Key growth factors

The latest technological advancements and rapid adoption in countries like Singapore, South Korea, China and Japan are driving the Asia Pacific market, with increasing focus on bioprinting.
India and Japan, along with China, have higher potential because of a greater emphasis on 3D printing of orthopedic equipment, which caters to the increased demand from the ageing population.
The rising demand for patient-centric products in orthopedics and maxillofacial surgery, and the availability of a range of material options like nylon, polymers, etc., and the reduction in the costs of 3D models have given a thrust to the adoption of 3D printing in various medical fields and are driving the market in the Asia-Pacific region.

Threats and key players

The utilization of 3D printing in healthcare is still expensive as far as tissues and organ printing are concerned. This is hindering growth in developing regions like the Asia-Pacific.
There is a lack of trained professionals, which is acting as an obstacle to the further development of 3D printing in the healthcare market.
The major players in the market are Stratasys Ltd., Organovo, Cellink, Renishaw, and Formlabs.

What is covered in the report?

1. Overview of the 3D printing in healthcare market in the Asia-Pacific region.
2. Market drivers and challenges in the 3D printing in healthcare market in the Asia-Pacific region.
3. Market trends in the 3D printing in healthcare market in the Asia-Pacific region.
4. Historical, current and forecasted market size data for the 3D printing in healthcare market in the Asia-Pacific region.
5. Historical, current and forecasted market size data for the segment based on technology [laser beam melting (LBM), electron beam melting (EBM), photopolymerization, droplet deposition, laminated object manufacturing, and others]
6. Historical, current and forecasted market size data for the segment based on material (plastic, metal, ceramic, and others).
7. Historical, current and forecasted market size data for the segment based on type (prosthetics, implants, surgical guides, hearing aid and others).
8. Historical, current and forecasted regional (China, India, Japan, South Korea, Australia and New Zealand (ANZ),and the he rest of Asia-Pacific) market size data for the 3D printing in healthcare market.
9. Analysis of the 3D printing in healthcare market in Asia-Pacific by value chain.
10. Analysis of the competitive landscape and profiles of major competitors operating in the market.

Why buy?

1. Understand the demand for 3D printing in healthcare to determine the viability of the market.
2. Identify the developed and emerging markets for 3D printing in healthcare.
3. Identify the challenges and address them.
4. Develop strategies based on the drivers, trends and highlights for each of the segments.
5. Evaluate the value chain to determine the workflow.
6. Recognize the key competitors of this market and respond accordingly.
7. Knowledge of the initiatives and growth strategies taken by the major companies and decide on the direction of further growth.

The post Asia-Pacific 3D Printing in Healthcare Market (2018-2023) first appeared on CRI Report.

Being the fastest growing region, Asia-Pacific has the major concern about medical services. The smart hospital brings the medical treatments in comparatively cheap expenses in the long run. The Asia-Pacific region has the potential to grow in smart hospital market, having a lot of companies and hospitals taking initiatives to install e-Health concept in their services. According to Netscribes, the Asia-Pacific smart hospital market is expected to have a significant compound annual growth rate of 28.40% and reach a market size of USD 14.59 Bn by 2023.
The increased use of mobile devices in the Asia-Pacific region has caused the growth of the market. It helps them to stay connected to the doctors on a real time basis and the patients health can be monitored quickly. Tele-consultation have become popular in countries like China and India, having a huge population and comparatively less number of doctors. It is easier for doctors to follow up and remotely supervise patients using the Internet of Things (IoT) and artificial intelligence (AI) which is growing in this region. Also, countries like India and Taiwan are becoming popular in Europe, North America and rest of the world for outbound medical tourism because of affordable medical expenses.

The Asia-Pacific smart hospital market is bifurcated on the basis of product (smart pills, mHealth, telemedicine, electronic health record and others), application (remote medicine management, electronic health record and clinical workflow, outpatient vigilance, medical connected imaging and medical assistance), artificial intelligence (offering and technology). The technologies used are AI, cloud computing, radio frequencies identification, wearable technologies, zigbee technologies, IoT and others. This region includes Japan, China, India and South Korea as majorly contributing countries.

Key growth factors

In the Asia-Pacific region, due to the collaborative working of the government and the private organizations, the smart hospital implementation has become easier. As the mobile devices have become popular, execution of IoT is at its peak. The concept of smart city is pushing the need for having smart hospitals and similar infrastructure in developing countries like India.

Threats and key players

As many countries in this region are in the stage of development, the smart hospital concept is still unaffordable for them. Also, cyber-security is one of the major issues to be concerned about. Cyber-attack is a major threat to smart hospitals.
The major players in the smart hospital market are Microsoft, GE Healthcare, Qualcomm Life, Philips, SAP, Siemens, Medtronic, STANLEY Healthcare, Cerner Corporation, Honeywell Life Care Solution etc.

Whats covered in the report?

1. Overview of the Asia-Pacific smart hospital market.
2. Historical, current and forecasted market size data for smart pills, mHealth, telemedicine, electronic health record and others.
3. Historical, current and forecasted market size data for remote medicine management, electronic health record and clinical workflow, outpatient vigilance, medical connected imaging and medical assistance.
4. Historical, current and forecasted market size data for offering and technology.
5. Historical, current and forecasted country wise (Japan, China, India and South Korea) market size data for Japan, China, India and South Korea smart hospital market segmentations by product (smart pills, mHealth, telemedicine, electronic health record and others), by application (remote medicine management, electronic health record and clinical workflow, outpatient vigilance, medical connected imaging and medical assistance), by artificial intelligence (offering and technology).
6. Market trends in the Asia-Pacific smart hospital market.
7. Qualitative analysis of the key drivers and challenges affecting the Asia-Pacific smart hospital market and its segments by product (smart pills, mHealth, telemedicine, electronic health record and others), by application (remote medicine management, electronic health record and clinical workflow, outpatient vigilance, medical connected imaging and medical assistance), by artificial intelligence (offering and technology)
8. Analysis of the competitive landscape and profiles of major players operating in the market

Why buy?

1. Get a broad understanding of the Asia-Pacific smart hospital market.
2. Get country-specific market size and observations for the Asia-Pacific smart hospital market and its segments by product (smart pills, mHealth, telemedicine, electronic health record and others), by application (remote medicine management, electronic health record and clinical workflow, outpatient vigilance, medical connected imaging and medical assistance), by artificial intelligence (offering and technology)
3. Get specific trends, drivers and challenges for the Asia-Pacific smart hospital market and its segments by product (smart pills, mHealth, telemedicine, electronic health record and others), by application (rem

The post Asia-Pacific Smart Hospital Market (2018-2023) first appeared on CRI Report.

Software-as-a-service (SaaS) is a kind of cloud computing in which a third-party provider manages applications and makes them accessible to consumers over the internet.

It removes the need for organisations to install and run applications on their computers or in their data centres, which eliminates the cost of hardware acquisition, provisioning and maintenance as well as software licensing, installation and support. The SaaS market is anticipated to grow at a compound annual growth rate (CAGR) of 34.28% during the forecast period 2018-2023.

Based on the deployment model, the SaaS market can be segmented into public cloud, private cloud and hybrid cloud. The private cloud and public cloud models are showing a positive trend in the market, and the companies are trying to employ the hybrid cloud model in the recent future. The public cloud market has the largest market share, whereas the hybrid cloud market is predicted to grow at the highest CAGR.

Healthcare Cloud Computing Market: Market Segments: By Service (IAAS, PAAS and SAAS); By Deployment Model (Public, Private and Hybrid Cloud); By Application (Clinical Information System and Non-clinical Information System); By Pricing Model Pay-as-you-go and Spot Pricing); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Depending on application, the SaaS market can be bifurcated into enterprise resource planning (ERP), customer relationship management (CRM), human resource management (HRM), supply chain management (SCM) and others. Other application types include web conferencing platforms, messaging applications and collaborations. HRM has the largest market share and is also predicted to have the highest growth rate in the forecast period.

By vertical, the SaaS market can be segmented into banking, financial services and insurance (BFSI), information technology (IT) and telecommunication, manufacturing, retail, healthcare, education, and others. The BFSI segment continues to hold the largest market share in the vertical segment. The manufacturing segment will be growing at a significant rate during the forecast period.

Japan is leading in SaaS adoption in the Asia-Pacific region. The country accounts for at least 40% of the regions SaaS expenditure. There are barriers in the Japanese market for the entry of most of the global SaaS companies as there is a tendency for the organizations to opt for home-grown solutions.

Key growth factors

Asian businesses are trying to maintain cost and functionality for their continuously changing business requirements. The need for innovation, agility, flexibility and speed in the business process increases the demand for SaaS-based solutions. Also, the countries of Asia-Pacific are still developing and are not at par with the developed regions. So, the primary concern is always the cost-efficiency. SaaS vendors offer solutions with lower operational expenses that help drive margins.

Threats and key players

Asian organisations are still fighting non-tech issues in their institutions such as corruption, weak government administration and lack of purchasing power. These problems are much lower in the value chain. While solving these problems, incorporating SaaS in their systems seem to be either a distraction or luxury for their businesses.

The key players in the market are Symantec Corporation, Google Inc., Fujitsu Ltd., Amazon.com Inc., IBM Corporation, HP, Oracle Corporation, SAP SE, Microsoft Corporation and Salesforce.

What’s covered in the report?

1. Overview of the SaaS market in the Asia-Pacific.
2. Market drivers and challenges in the SaaS market in Asia-Pacific.
3. Market trends in the SaaS market in Asia-Pacific.
4. Historical, current and forecasted market size data for the SaaS market in Asia-Pacific.
5. Historical, current and forecasted market size data for the deployment segment (public cloud, private cloud and hybrid cloud).
6. Historical, current and forecasted market size data for the application segment (ERP, CRM, HRM, SCM and others).
7. Historical, current and forecasted market size data for the vertical segment (BFSI, IT and telecommunication, manufacturing, retail, healthcare, education and others).
8. Histo

https://www.cri-report.com/product/global-software-as-a-service-saas-market-2018-2023/

The post Asia-Pacific Software-as-a-Service (SaaS) Market 2018-2023 first appeared on CRI Report.

Asia-Pacific is the fastest growing precision medicine market in the world. Major countries like China, India and Japan are adopting healthcare technologies at a rapid pace, resulting in improvements in the treatments and solutions for uncommon diseases. This is why the demand for precision medicine is also increasing. The market is expected to expand in the region because of advancements in recent research which are helping in the diagnosis of diseases, its appropriate risks and optimal therapy. According to Netscribes, the Asia-Pacific precision medicine market is projected to grow at a compound annual growth rate (CAGR) of 16.63%, leading to a revenue of USD 20.90 Bn by 2023.
China is dominating the precision medicine market due to its ageing population and rise in the rate of chronic diseases. India is experiencing the fastest growth in the Asia- Pacific region. Rising investments in research and development have also triggered the growth of the precision medicine market.

The Asia-Pacific precision medicine market is classified into three primary segments: based on ecosystem players: pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies; based on therapeutics: cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases; and based on technology: big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics.
Diagnostic tool companies are expected to exhibit the highest growth rate in the region due to increased investments in research and technology, and clinical trials in the region. The cancer therapeutics segment is expected to register the highest growth rate during the forecasted period 2018-2023 due to higher incidence of cancer.

Key growth factors

The adoption of gene therapy – which is essential for the development of precision medicine – is responsible for the growth of the market. Further, the increasing rate of chronic diseases and enhancements in big data analytics will also drive the precision medicine market during the forecasted period of 2018-2023.
Asia-Pacific is expected to become one of the most prominent markets by 2023 for precision medicine because of favorable reimbursement policies which will help businesses expand across borders.

Threats and key players

There is limited adoption (less than 50%) of electronic health records in Asia-Pacific countries like India, Indonesia, etc. This is resulting in the absence of proper healthcare information systems, which are important components of precision medicine to capture vital patient data. This limits the deployment of advanced healthcare solutions like precision medicine.
The adoption of high-end genomic technologies and artificial intelligence tools like N-of-One, WuxiNextCode, etc., are expected to face difficulties in the region due to inadequate healthcare facilities.
The major players operating in the Asia-Pacific precision medicine market are Pfizer, Novartis, Teva pharmaceuticals Industries etc.

Whats covered in the report?

1. Overview of the Asia-Pacific precision medicine market.
2. Market drivers and challenges in the Asia-Pacific precision medicine market.
3. Market trends in the Asia-Pacific precision medicine market.
4. Historical, current, and forecasted market size data for the segments of the Asia-Pacific precision medicine market, based on ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies)  by revenue (USD Bn).
5. Historical, current and forecasted market size data for the segments of the Asia-Pacific precision medicine market , based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases)  by revenue (USD Bn).
6. Historical, current and forecasted market size data for the Asia-Pacific precision medicine market segmentation by technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics) – by revenue (USD Bn).
7. Historical, current and forecasted country-wise (China, India and Japan) market size data (USD Bn) for the Asia-Pacific precision medicine market and its segmentations by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies), by therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder and infecti

The post Asia-Pacific Precision Medicine Market (2018-2023) first appeared on CRI Report.

The value of the machine learning market in Asia-Pacific is expected to reach USD 10.00 Bn by 2023, expanding at a compound annual growth rate (CAGR) of 51.3% during 2018-2023.
Machine learning the ability of computers to learn through experiences to improve their performance. Separate algorithms and human intervention are not required to train the computer. It merely learns from its past experiences and examples. In recent times, this market has gained utmost importance due to the increased availability of data and the need to process the data to obtain meaningful insights.
Asia-Pacific will experience the highest CAGR in the machine learning market.

The market can be classified into four primary segments based on components, service, organization size and application.
Based on region, the market is segmented into China, India, Japan, South Korea, Australia and New Zealand (ANZ), the rest of Asia-Pacific.
Based on components the market can be segmented into software tools, cloud and web-based application programming interfaces (APIs) and others.
Based on service, the sub-segments are composed of professional services and managed services.
Based on organization size, the sub-segments include small and medium enterprises (SMEs) and large enterprises.
Based on application, the market is divided into the sub-segments, banking, financial services and insurance (BFSI), automotive, healthcare, government and others.
Machine learning is no longer a novelty in Asia-Pacific countries. Business sectors having realised its potential are using machine learning technologies to draw maximum insights from the available data to increase the efficiency of operations.

Key growth factors

The enormous population base together with a diverse industry mix, which has the potential to generate a huge amount of data, is significantly driving the machine learning market in the Asia-Pacific countries.
The availability of a robust data set, the adoption of machine learning techniques in traditional industries and strengthening of the pipeline of cohorts with exceptional talent is driving the machine learning market in the Asia-Pacific region.

Threats and key players

Ethical issues and biased data leading to biased decisions are a matter of concern which restricts further development of the machine learning market.
The connectivity standards available in the Asia-pacific region still falls below the worlds average. The digital divide is widening the gap among the sub-regions in the Asia-Pacific zone at an alarming rate. This again is causing a hindrance to the development in the machine learning market in this region.
The key players are Microsoft, Google Inc., IBM Watson, Amazon, Baidu, Intel, Facebook, Apple Inc., and Uber.

What is covered in the report?

1. Overview of the machine learning market in Asia-Pacific region.
2. Market drivers and challenges in the machine learning market in Asia-Pacific region.
3. Market trends in the machine learning market in Asia-Pacific region.
4. Historical, current and forecasted market size data for the machine learning market in Asia-Pacific region.
5. Historical, current and forecasted market size data for the components segment (software tools, cloud and web-based APIs and others).
6. Historical, current and forecasted market size data for the service segment (professional services and managed services).
7. Historical, current and forecasted market size data for the organisation size segment (SMEs and large enterprises).
8. Historical, current and forecasted market size data for the application segment (BFSI, automotive, healthcare, government and others).
9. Historical, current and forecasted regional (China, India, Japan, South Korea, Australia and New Zealand (ANZ), the rest of Asia-Pacific) market size data for machine learning market.
10. Analysis of the machine learning market in Asia-Pacific by value chain.
11. Analysis of the competitive landscape and profiles of major compet

The post Asia-Pacific Machine Learning Market (2018-2023) first appeared on CRI Report.

The Asia-Pacific nutritional supplement market was worth USD 44.02 Bn in 2017. This market is expected to witness the fastest growth at a CAGR of 14.63% from the period of 2018 to 2023. Personalized nutrition is emerging as a major trend in this market. Growing awareness about the need for nutritional supplements in China and India is acting in favour of the market.
By type of ingredients, the market is segmented Vitamins, Proteins, Amino acids, Enzymes and Botanicals supplements. Botanicals supplements has the highest share in Asia-Pacific in 2018.

By end-user, the market is segmented into Infants and Adults.
By countries, the market is divided into China, India, Japan and Others (Rest of Asia-Pacific).

Key growth factors

Increased consumer awareness regarding the benefits of dietary supplements and wide product availability are some of the major drivers in Asia-Pacific. Increase in the disposable income allows people to spend more on nutritional supplements. The use of traditional herbal supplements such as tulsi, aswagandha and turmeric due to their medicinal benefits is also a key driver for this market.

Threats and key players

Lack of awareness about the dosage of nutritional supplements and strict government regulations and guidelines is considered to be one of the challenges for this market.
The key players operating in the Asia-Pacific nutritional supplement market are Abbott Nutritionals, GlaxoSmithKline, Amway Asia-Pacific Ltd , Bayer AG and Arkopharma Laboratories.

What’s covered in the report?

1. Overview of the Asia-Pacific Nutritional Supplement Market
2. Market drivers, challenges, in Asia-Pacific Nutritional Supplement Market
3. Market trends in Asia-Pacific Nutritional Supplement Market
4. Historical, current and forecasted market size data for Asia-Pacific market segmentation based on type of ingredients (Vitamins, Proteins, Amino acids, Enzymes and Botanicals) – by revenue
5. Historical, current and forecasted market size data for Asia-Pacific market segmentation based on End-user (Infants and Adults) – by revenue
6. Historical, current and forecasted market size data of Nutritional Supplements by countries China, India, Japan and others (Rest of Asia-Pacific) – by revenue
7. Historical, current and forecasted market size data for country-wise segments – by revenue
8. Analysis of the competitive landscape and profiles of major competitors operating in the Asia-Pacific market

Why buy?

o Understand the demand for Nutritional Supplement Market to determine the viability of the market
o Understand the country-specific market size and observations for each segment
o Develop strategies based on the drivers, trends and highlights for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken by the major companies and decide the direction of further growth
o Define the competitive positioning by comparing the products and services compared with the key players in the market

The post Asia-Pacific Nutritional Supplement Market (2018-2023) first appeared on CRI Report.

Asia-Pacific is a rapidly growing cancer market. The market is forecasted to grow at a compound annual growth rate (CAGR) of 17.3% resulting in annual revenue of USD 32.26 Bn during the forecast period (2018-2023). Asia Pacific is rapidly adopting the latest technological developments and is contributing towards exhaustive research initiatives to contribute to the growth of the cancer screening market.

By end users, the market is segmented into hospitals, laboratories, and independent physicians and clinics. Laboratories segment will witness a progressive growth during the forecast period 2018-2023 while the hospital segment will account for the maximum revenue of USD 11.18 Bn during the forecast period.
By screening type, the market is segmented into laboratory, genetic, imaging, biopsy and endoscopy tests. Genetic, biopsy and endoscopy will be the leading segments during the forecast period 2018-2023.
By application type, the market can be segmented into lung, breast, melanoma, kidney and colorectal cancer types. Colorectal, kidney, melanoma and breast cancer will occupy a larger share of the market during the forecast period 2018-2023.
By countries, the market is divided into India, China and the rest of Asia-Pacific.

Key growth factors

The growing patient pool in India, China nd Japan ue to the support in diagnostic process at comparatively lower prices, and a favourable regulatory framework are some of the factors boosting the market growth in this region.

Threats and key players

Regional trade barriers and stringent regulations will act as the obstacles. The need to adopt advanced technologies will aggravate the need for skilled professionals. Transparency in medicinal treatments will be a key challenge for the region.
Key players in the Asia-Pacific cancer screening market are Abbott diagnostics, GE healthcare, Hologic Inc., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc.

What is covered in the report?

1. Overview of the Asia-Pacific cancer screening market.
2. Market drivers and challenges in Asia-Pacific cancer screening market.
3. Market trends in the Asia-Pacific cancer screening market.
4. Historical, current and forecasted market size data for the Asia-Pacific market segmentation based on type of end users (Hospitals, laboratories, independent physicians and clinics) – by screening type(Laboratory, genetic, imaging, biopsy and endoscopy) –by application (Lung, breast, melanoma, kidney and colorectal).
5. Historical, current and forecasted market size data for the Asia-Pacific market segmentation based on end users (hospitals, laboratory, independent physicians and clinics) – by screening type(Laboratory, genetic, imaging, biopsy and endoscopy) –by application lung, breast, melanoma, kidney and colorectal).
6. Historical, current and forecasted market size data of the cancer screening market by countries and others (other parts of Europe) – by revenue.
7. Historical, current and forecasted market size data for country-wise segments – by revenue.
8. Analysis of the competitive landscape and profiles of major competitors operating in the European market.

Why buy?

o Understand the demand for cancer screening market to determine the viability of the market.
o Understand the country-specific market size and observations for each segment.
o Develop strategies based on the drivers, trends and highlights for each of the segments.
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
o Recognize the key competitors of this market and respond accordingly.
o Identify the initiatives and growth strategies taken by the major companies and decide the direction of further growth.
o Define the competitive positioning by comparing the products and services with the key players in the market.

The post Asia Pacific Cancer Screening Market (2018-2023) first appeared on CRI Report.

ADAS are systems that support, complement, or substitute the driver of a vehicle. These systems help drivers to avoid collisions and accidents. It is a set of systems used in vehicles to provide an intelligent and comfortable driving experience. They use radar and cameras to assist the drivers by providing real-time information about the surroundings. ADAS is leading the way to autonomous vehicles. These systems are the foundation of next-generation automotive electronic safety systems and autonomous cars. A vehicle’s ADAS can detect objects, alert the driver of hazardous conditions or impending danger. The Asia-Pacific ADAS market is expected to reach USD 9.69 Bn by 2023 with a CAGR of 28.6% during 2018-2023.
The ADAS market in the Asia Pacific is anticipated to witness a substantial and rapid growth over the next decade due to various developments in its major economies, especially the market in China.

The market is divided into three primary segments based on vehicle, sensor and component.
Based on vehicle, the market is segmented into passenger and commercial vehicles.
Based on sensors, the market is divided into image, radar, lidar and other sensors (ultrasonic,
infrared and laser sensors).
Based on components, the market is classified into adaptive cruise control (ACC), parking assistance (PA), lane departure warning (LDW), tire pressure monitoring (TPM), blind spot detection (BSD), autonomous emergency braking (AEB) and others (adaptive front lighting, drowsiness monitor, forward collision warning, head-up display and driver monitoring systems).
On the basis of countries, the market is segmented into China, Japan, India, and Rest of Asia-Pacific (APAC).

Key growth factors

The increasing government initiatives for mandating driver assistance system in order to lower road accidents is expected to proliferate market growth. Higher adoption of these systems in small cars is anticipated to further boost the market demand. Rising levels of technological innovation, as well as growing initiatives towards vehicle automation and self-drive cars have raised the demand for the safety of the driver and assistance systems over the past decade. The adoption of ADAS applications such as ACC, BSD, LDW and night vision are leading to reduction in the number of accidents. The growing need for a safe driving environment has led to the demand for comfort driving among people. Rising per capita income and government safety regulations are also contributing to the growth of the safety systems in the automotive industry.

Threats and key players

The growth of the ADAS market is currently hindered by the growing incidence of software failures in sensors coupled with the high cost of these systems that have acted as major restraining factors for the wide acceptability of these systems. In the rapidly growing vehicle automation and ADAS market, the big challenge is to improve system accuracy and performance without hiking the price. In China, not every ADAS technology will experience significant growth in the near future. Some systems like night vision, driver monitoring, multi-view systems, intelligent speed adaptation and night vision are anticipated to display restrained growth in the coming years.
The key competitors in the Asia-Pacific ADAS market are Continental AG, Autoliv Inc., Delphi Technologies, Denso Corporation, Bosch and others.

What’s covered in the report?

1. Overview of the Asia-Pacific ADAS learning market.
2. Market drivers and challenges of the Asia-Pacific ADAS market.
3. Market trends in the Asia-Pacific ADAS market.
4. Historical, current and forecasted market size data for the segment based on vehicles.
5. Historical, current and forecasted market size data for the segment based on sensors.
6. Historical, current and forecasted market size data for the segment based on components.
7. Historical, current and forecasted country-wise (China, Japan, India, and Rest of APAC) market size data for the ADAS market.
8. Historical, current and forecasted market size data for country-wise segments.
9. Analysis of company profiles of major competitors operating in the market.

Why buy?

o Understand the demand for ADAS to determine the viability of the market
o Identify the challenge areas and address them
o Develop strategies based on the drivers, trends and highlights
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Knowledge of the initiatives and growth strategies taken by the major companies and decide the direction of further growth
o Define the competitive positioning by comparing the products and services compared with the key players in the market

ADAS and Autonomous Sensor Maintenance Equipment Market – A Global and Regional Analysis: Focus on Product Type, Application Type, Level of Autonomy, and Region – Analysis and Forecast, 2021-2031

The post Asia-Pacific Advanced Driver Assistance Systems (ADAS) Market (2018-2023) first appeared on CRI Report.